We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-0.98%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$876M
AUM Growth
-$55.2M
(-5.9%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-2.58%
Top 10 Holdings %
Top 10 Hldgs %
15.65%
Holding
1,097
New
348
Increased
154
Reduced
158
Closed
436
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$13.9M |
| 2 |
CVS Health
CVS
|
+$12.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$11.6M |
| 4 |
Skyworks Solutions
SWKS
|
+$10.5M |
| 5 |
Nike
NKE
|
+$9.75M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.9M |
| 2 |
Starbucks
SBUX
|
+$11.8M |
| 3 |
Goldman Sachs
GS
|
+$10.9M |
| 4 |
Coca-Cola
KO
|
+$8.98M |
| 5 |
T-Mobile US
TMUS
|
+$8.67M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.2% |
| 2 | Healthcare | 13.88% |
| 3 | Consumer Discretionary | 12.26% |
| 4 | Financials | 8.85% |
| 5 | Communication Services | 8.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Revolution Medicines
RVMD
$40.9B
| $289K | 0.03% |
+10,432
| New | +$309K |
|
477
Denali Therapeutics
DNLI
$3.86B
| $288K | 0.03% |
+13,942
| New | +$354K |
|
478
Toronto Dominion Bank
TD
$198B
| $287K | 0.03% |
+4,757
| New | +$297K |
|
|
AKRO
479
DELISTED
Akero Therapeutics
AKRO
| $285K | 0.03% |
+5,634
| New | +$262K |
|
480
Prosperity Bancshares
PB
$8.97B
| $284K | 0.03% |
5,206
-3,000
| -37% | -$174K |
|
481
PJT Partners
PJT
$4.33B
| $284K | 0.03% |
+3,569
| New | +$276K |
|
482
Teleflex
TFX
$5.86B
| $280K | 0.03% |
+1,428
| New | +$324K |
|
483
Vistra
VST
$50.1B
| $279K | 0.03% |
+8,421
| New | +$253K |
|
484
Magnolia Oil & Gas
MGY
$5.93B
| $278K | 0.03% |
12,121
-42,800
| -78% | -$956K |
|
485
Royal Bank of Canada
RY
$292B
| $278K | 0.03% |
+3,174
| New | +$295K |
|
486
KBR
KBR
$4.36B
| $277K | 0.03% |
+4,700
| New | +$290K |
|
487
Goosehead Insurance
GSHD
$2.27B
| $276K | 0.03% |
+3,707
| New | +$249K |
|
488
MillerKnoll
MLKN
$1.53B
| $276K | 0.03% |
+11,295
| New | +$211K |
|
489
Grupo Cibest SA
CIB
$22.3B
| $275K | 0.03% |
+10,293
| New | +$286K |
|
490
CryoPort
CYRX
$773M
| $274K | 0.03% |
+20,000
| New | +$294K |
|
491
ADMA Biologics
ADMA
$2.01B
| $272K | 0.03% |
+76,100
| New | +$293K |
|
|
SFBS
492
ServisFirst Bancshares
SFBS
$4.88B
| $271K | 0.03% |
+5,185
| New | +$274K |
|
493
Coinbase
COIN
$43.1B
| $270K | 0.03% |
3,600
-90,133
| -96% | -$7.6M |
|
494
American Homes 4 Rent
AMH
$11.9B
| $270K | 0.03% |
+8,000
| New | +$287K |
|
495
ProFrac Holding
ACDC
$671M
| $269K | 0.03% |
+24,700
| New | +$286K |
|
496
Brady Corp
BRC
$4.39B
| $267K | 0.03% |
4,865
-3,129
| -39% | -$161K |
|
497
Flex
FLEX
$41B
| $267K | 0.03% |
+13,137
| New | +$266K |
|
498
Cullen/Frost Bankers
CFR
$10.3B
| $264K | 0.03% |
2,889
-4,000
| -58% | -$406K |
|
|
CUK
499
DELISTED
Carnival PLC
CUK
| $262K | 0.03% |
+21,418
| New | +$321K |
|
|
VSXY
500
Victoria's Secret
VSXY
$7.01B
| $261K | 0.03% |
+15,668
| New | +$296K |
|
Similar funds
KL
FWS
AGFVA
1C
MP
FLC
APW
QM
Bayesian Capital Management's Q3 2023 Portfolio in Review
As of Q3 2023, Bayesian Capital Management held 1,097 positions worth $876M, down 5.9% from $931M the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bayesian Capital Management's Q3 2023 filing shows 348 new, 154 increased, 158 reduced and 436 closed positions. Its largest new stake was Walt Disney: 162,687 shares worth $13.2M. The largest sale was NVIDIA, an estimated $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2023 buy was Walt Disney: 162,687 shares worth $13.2M.
- Bayesian Capital Management added most to CVS Health in Q3 2023, an estimated $12.2M increase.
- Bayesian Capital Management's biggest Q3 2023 reduction was Coca-Cola, cutting an estimated $8.98M.
- Bayesian Capital Management fully exited NVIDIA in Q3 2023, selling an estimated $27.9M.
- Bayesian Capital Management's ten largest holdings make up 16% of its $876M portfolio in Q3 2023.
- Bayesian Capital Management opened 348 new positions and closed 436 in Q3 2023.
- Bayesian Capital Management's portfolio value fell 5.9% quarter-over-quarter to $876M.
Based on Bayesian Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.